Every one of those 1 sits in a single category, earnings. Catherine Owen Adams is most often covered alongside Acadia Pharmaceuticals, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3.2 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Catherine Owen Adams
Every one of those 1 sits in a single category, earnings. Catherine Owen Adams is most often covered alongside Acadia Pharmaceuticals, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3.2 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 6.2 for that window. We currently track 1 Finance story that mention Catherine Owen Adams, all published on February 27, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 91 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Catherine Owen Adams. Shared-story counts are live from our verified record — not editorial picks.
ACADIA Pharmaceuticals and Alkami Technology reported Q4 results that highlight divergent paths for mid-cap growth entities. While ACADIA focuses on the commercial scaling of its rare disease portfolio, Alkami is battling a significant stock correction despite beating revenue expectations.
Catherine Owen Adams is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.